Cyclophosphamide for Dogs: A Workhorse Chemotherapy Drug, Explained

Cyclophosphamide is one of the most widely used chemotherapy drugs in veterinary medicine. It can do a lot of good — improving both quality of life and survival time for dogs with several kinds of cancer — but it's a potent medication that comes with real side effects. If your dog's treatment plan includes cyclophosphamide, here's a clear, plain-language guide to what it is, how it works, what it treats, and how to use and handle it safely.

What Cyclophosphamide Is

Cyclophosphamide belongs to a class of drugs called nitrogen mustards — cell-killing compounds that, interestingly, trace their origins to chemical warfare agents before being repurposed as some of the very first cancer chemotherapies. (Quite the career change.) Today it's a mainstay of cancer care in both human and veterinary medicine.

It comes as a tablet or oral liquid that can be given by mouth, and also as an injectable solution. In people it's sold under brand names such as Cytoxan® and Neosar® (and Procytox® in Canada). There's no version specifically approved for animals, so when it's used in dogs it's prescribed "off-label" — a routine and accepted practice, since most veterinary drugs were originally developed for humans.

How Cyclophosphamide Works

Cyclophosphamide is what's known as a "pro-drug," meaning it arrives in the body inactive and has to be switched on. The liver does that job, converting it into an active form (aldophosphamide and, ultimately, the working compound phosphoramide mustard).

Once active, it works as an alkylating agent: it latches onto DNA and cross-links the two strands together, essentially knotting up the genetic code so a cell can't unwind and copy it. A cell that can't copy its DNA can't divide — and since cancer cells divide constantly, they're hit hard. The catch is that cyclophosphamide can't tell the difference between a cancer cell and any other fast-dividing cell, so it also affects bone marrow, hair follicles, the lining of the intestines, and developing fetal cells. That's the root of most of its side effects.

What Cyclophosphamide Treats

Cyclophosphamide's claim to fame in dogs is its role in the CHOP protocol for lymphoma — the "C" in CHOP stands for cyclophosphamide. (The other letters are doxorubicin, vincristine, and prednisone.) But its usefulness goes well beyond that.

In dogs, it's used against lymphoma, leukemia, various carcinomas, and sarcomas, and studies have reported improved survival times in dogs with lymphoma and with oral cancers. One retrospective study of dogs with malignant mammary (breast) tumors found that a large share of patients — about 78% — responded to cyclophosphamide-based treatment. In people, the same drug treats an even broader list, including lymphoma, leukemia, multiple myeloma, neuroblastoma, retinoblastoma, ovarian cancer, and breast cancer.

It's frequently combined with other drugs to boost results — whether as part of a multi-drug protocol like CHOP or paired with a non-steroidal anti-inflammatory (NSAID). It can also be given in small, frequent doses over time, an approach called metronomic chemotherapy, which aims to keep side effects low while slowing a tumor's blood supply rather than blasting the cancer directly.

Beyond cancer: Because cyclophosphamide suppresses the immune system, it's occasionally used for severe immune-mediated diseases such as life-threatening immune-mediated hemolytic anemia (IMHA), usually alongside prednisone. Given its side effects, though, it's generally reserved for the most serious cases.

The Side Effect to Understand: Hemorrhagic Cystitis

Most of cyclophosphamide's side effects overlap with other chemo drugs, but one is distinctive enough to deserve its own spotlight: sterile hemorrhagic cystitis, a painful, bleeding inflammation of the bladder. It happens because one of the drug's breakdown products (acrolein) is irritating to the bladder lining and concentrates there in the urine.

The good news is that it's largely preventable, and your oncologist will plan for it. Common strategies include giving the dose in the morning, encouraging plenty of water intake, and making sure your dog empties their bladder frequently so the irritating byproduct doesn't sit in contact with the bladder wall. Sometimes a steroid (which increases drinking and urination) is given alongside it, and in higher-dose settings a protective drug called mesna may be used. If you ever notice blood in your dog's urine, straining to urinate, or frequent small urinations, contact your vet right away — and importantly, this can develop even after the drug is stopped.

Other Side Effects to Watch For

Cyclophosphamide's other potential side effects include:

• Gastrointestinal upset — the most common issue, including nausea, vomiting, and diarrhea
• Bone marrow suppression — lower blood-cell counts, especially neutropenia (low infection-fighting white blood cells), which can raise infection risk
• Hair loss — more pronounced in continuously growing coats (breeds like Poodles)
• Fever

Because of the bone marrow effects, your vet will check bloodwork before and during treatment. Call your oncologist immediately if you see signs that can point to low blood counts — unexplained bruising or bleeding, fever, or lethargy and weakness — or any blood in the urine.

When Cyclophosphamide Might Not Be the Right Choice

Cyclophosphamide generally isn't used in dogs with a known allergy to it, a urinary obstruction or urinary tract infection, or existing bone marrow problems. It's used cautiously in dogs with liver or kidney issues, those getting radiation therapy, and dogs prone to infection. It should be avoided in pregnancy except as a last resort, and if a nursing dog must take it, the puppies should be switched to milk replacer to avoid exposure.

It also interacts with a long list of medications. These interactions don't always rule out using the drug, but they can raise the risk of side effects or call for dose adjustments. Reported interactions include allopurinol, heart-toxic (cardiotoxic) drugs, chloramphenicol, dexamethasone, other immunosuppressants, methimazole, thiazide diuretics, ondansetron, phenytoin, phenobarbital, warfarin, and live vaccines. This is exactly why every veterinarian treating your dog needs a complete, current list of all medications and supplements your dog is taking.

How It's Given, and What to Do About a Missed Dose

The oral pill and liquid forms can be given at home; the injectable form is administered only at the veterinary hospital. The exact dose and schedule depend on the cancer type, the protocol your vet is using, and how well your dog tolerates the drug — and the schedule may be adjusted along the way if side effects appear.

Cyclophosphamide's dosing is carefully calculated, so if you miss a dose, don't simply give it whenever you remember. Call your veterinary team for guidance — with a chemotherapy drug, it's always safer to ask than to guess.

Storage and Safe Handling at Home

Store tablets at room temperature (about 68–77 °F) and protected from light. Liquid (compounded) formulations can typically be refrigerated for up to about two weeks. Dispose of any leftover medication through a community drug "take-back" program rather than the trash or toilet.

Cyclophosphamide is a hazardous drug, so handling matters — both the medication itself and your dog's waste after treatment:

• Wear disposable gloves to handle the tablets or liquid, and discard them right after.
• Remember the drug shows up in your dog's saliva, urine, feces, and vomit for a few days after a dose.
• Wear gloves to clean up any urine, stool, or vomit, and wash your hands afterward.
• Don't let your dog lick your face or hands in the days following treatment.
• Anyone who is pregnant or nursing should not handle the drug or your dog's waste at all — cyclophosphamide can cause birth defects.

The Bottom Line

Cyclophosphamide is a hardworking, versatile chemotherapy drug that has earned its central place in canine cancer care, especially for lymphoma. It's potent, and that power cuts both ways: it can meaningfully help, but it requires careful dosing, monitoring, and handling, with special attention to its bladder and bone marrow effects. Used thoughtfully and under the close guidance of your veterinarian or veterinary oncologist, it can be a valuable part of giving your dog more good time — and feeling well during it.

This article is for educational purposes and reflects the current state of veterinary research; it isn't a substitute for individualized veterinary advice. Always consult your veterinarian or a veterinary oncologist before starting, stopping, or changing any treatment for your dog.

References

Brooks, W. (2021). Cyclophosphamide (Cytoxan, Neosar). Veterinary Partner. https://veterinarypartner.vin.com/

DrugBank. (2023). Cyclophosphamide. https://go.drugbank.com/drugs/DB00531

Gollakner, R. (n.d.). Cyclophosphamide. VCA Animal Hospitals. https://vcahospitals.com/know-your-pet/cyclophosphamide

Krick, E. L. (2011, November/December). Lymphoma in dogs and cats: What's the latest? Today's Veterinary Practice. https://todaysveterinarypractice.com/oncology/lymphoma-in-dogs-cats-whats-the-latest/

Lori, J. C., Stein, T. J., & Thamm, D. H. (2010). Doxorubicin and cyclophosphamide for the treatment of canine lymphoma: A randomized, placebo-controlled study. Veterinary and Comparative Oncology, 8(3), 188–196. https://doi.org/10.1111/j.1476-5829.2009.00210.x

Milevoj, N., Tozon, N., Licen, S., Long, F., & Nemec Svete, A. (2022). Metronomic chemotherapy for the palliative treatment of malignant oral tumors in dogs. Frontiers in Veterinary Science, 9, 856399. https://doi.org/10.3389/fvets.2022.856399

Musser, M. L., Berger, E. P., Tripp, C. D., Clifford, C. A., Bergman, P. J., & Johannes, C. M. (2021). A retrospective evaluation of chemotherapy overdoses in dogs and cats. Frontiers in Veterinary Science, 8, 718967. https://doi.org/10.3389/fvets.2021.718967

Suryawanshi, R. V., Gajbhiye, S. V., Pawar, V. R., & Joshi, M. (2021). Assessment of efficacy and toxicity of cyclophosphamide chemotherapy in canines with malignant mammary tumor: A retrospective study. Veterinary Medicine International, 2021, 5520603. https://doi.org/10.1155/2021/5520603